Merck’s remigromig meets non-inferiority goal in DME trial
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
Moderna Now Trades 61% Above Wall Street's Average Price Target. Should You Sell?
After a few years of stagnation, this stock is soaring.
Today’s Wordle #1940: Hints, Clues And Answer For Sunday October 11
Looking for help with today's New York Times Wordle? Here are some expert hints, clues and commentary to help you solve today's Wordle and sharpen your guessing game.
